Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillin tablets for prevention and treatment of radiation-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR2300072385Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Qinzhou
- Start
- Jul 2023
- Countries
- 1
01
Overview
Phase 4 trial of Lactobacillin in stomatitis (2 arms), sponsored by The First People's Hospital of Qinzhou. Primary endpoints: Incidence and severity of radiation-induced oral mucositis and Inflammatory cytokines. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
Lactobacillin
03
Conditions
stomatitis
Beyond the preview
Go deeper on ChiCTR2300072385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072385.